| Structural basis for viral late-domain binding to Alix S Lee, A Joshi, K Nagashima, EO Freed, JH Hurley Nature structural & molecular biology 14 (3), 194-199, 2007 | 178 | 2007 |
| HIV-1 induced bystander apoptosis H Garg, J Mohl, A Joshi Viruses 4 (11), 3020-3043, 2012 | 170 | 2012 |
| Point mutations in the HIV-1 matrix protein turn off the myristyl switch JS Saad, E Loeliger, P Luncsford, M Liriano, J Tai, A Kim, J Miller, A Joshi, ... Journal of molecular biology 366 (2), 574-585, 2007 | 149 | 2007 |
| Strategies for targeted nonviral delivery of siRNAs in vivo SS Kim, H Garg, A Joshi, N Manjunath Trends in molecular medicine 15 (11), 491-500, 2009 | 148 | 2009 |
| Human immunodeficiency viruses regulated by alternative trans‐activators: genetic evidence for a novel non‐transcriptional function of Tat in virion infectivity. L Huang, A Joshi, R Willey, J Orenstein, KT Jeang The EMBO Journal 13 (12), 2886-2896, 1994 | 125 | 1994 |
| Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay A Ono, AA Waheed, A Joshi, EO Freed Journal of virology 79 (22), 14131-14140, 2005 | 99 | 2005 |
| Preferential replication of FIV in activated CD4+ CD25+ T cells independent of cellular proliferation A Joshi, TW Vahlenkamp, H Garg, WAF Tompkins, MB Tompkins Virology 321 (2), 307-322, 2004 | 96 | 2004 |
| Development of virus-like-particle vaccine and reporter assay for Zika virus H Garg, M Sedano, G Plata, EB Punke, A Joshi Journal of virology 91 (20), 10.1128/jvi. 00834-17, 2017 | 95 | 2017 |
| Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment A Joshi, SD Ablan, F Soheilian, K Nagashima, EO Freed Journal of virology 83 (11), 5375-5387, 2009 | 88 | 2009 |
| Virus like particles (VLP) as multivalent vaccine candidate against chikungunya, Japanese encephalitis, yellow fever and zika virus H Garg, T Mehmetoglu-Gurbuz, A Joshi Scientific Reports 10 (1), 4017, 2020 | 85 | 2020 |
| Functional replacement of a retroviral late domain by ubiquitin fusion A Joshi, U Munshi, SD Ablan, K Nagashima, EO Freed Traffic 9 (11), 1972-1983, 2008 | 82 | 2008 |
| GGA and Arf proteins modulate retrovirus assembly and release A Joshi, H Garg, K Nagashima, JS Bonifacino, EO Freed Molecular cell 30 (2), 227-238, 2008 | 81 | 2008 |
| Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation A Joshi, K Nagashima, EO Freed Journal of virology 80 (16), 7939-7951, 2006 | 75 | 2006 |
| Preferential Feline Immunodeficiency Virus (FIV) Infection of CD4+ CD25+ T-Regulatory Cells Correlates both with Surface Expression of CXCR4 and Activation of … A Joshi, H Garg, MB Tompkins, WA Tompkins Journal of virology 79 (8), 4965-4976, 2005 | 63 | 2005 |
| Site-specific mutations in HIV-1 gp41 reveal a correlation between HIV-1-mediated bystander apoptosis and fusion/hemifusion H Garg, A Joshi, EO Freed, R Blumenthal Journal of Biological Chemistry 282 (23), 16899-16906, 2007 | 56 | 2007 |
| Host and viral factors in HIV-mediated bystander apoptosis H Garg, A Joshi Viruses 9 (8), 237, 2017 | 43 | 2017 |
| Cardiovascular complications of HIV infection and treatment H Garg, A Joshi, D Mukherjee Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly …, 2013 | 43 | 2013 |
| HIV ENV glycoprotein-mediated bystander apoptosis depends on expression of the CCR5 co-receptor at the cell surface and ENV fusogenic activity A Joshi, AM Nyakeriga, R Ravi, H Garg Journal of Biological Chemistry 286 (42), 36404-36413, 2011 | 42 | 2011 |
| Recent advances in Zika virus vaccines H Garg, T Mehmetoglu-Gurbuz, A Joshi Viruses 10 (11), 631, 2018 | 37 | 2018 |
| TCR‐induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56lck residues AM Nyakeriga, H Garg, A Joshi Cytometry Part A 81 (9), 797-805, 2012 | 36 | 2012 |
